Advertisement

Impact of Provider Recommendation on Tdap Vaccination of Adolescents Aged 13–17 Years

      Introduction

      Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination has been recommended for adolescents in the U.S. since 2006. Information on Tdap vaccination by provider recommendation is limited. The purpose of this study is to assess recent Tdap vaccination by provider recommendation status among adolescents aged 13–17 years.

      Methods

      The 2013 National Immunization Survey-Teen data (N=18,948) were analyzed in 2016 to assess national and state-specific Tdap vaccination coverage disparities among adolescents by provider recommendation status, and other demographic and access to care variables. Multivariable logistic regression analysis and predictive marginal modeling evaluated associations between Tdap vaccination and provider recommendation status and other factors among adolescents aged 13–17 years.

      Results

      Overall, only 56.9% of adolescents aged 13–17 years received a provider recommendation for Tdap. Coverage was significantly higher among adolescents with a provider recommendation (88.6%) compared with those without a provider recommendation (80.5%) (p<0.05). Multivariable logistic regression showed that characteristics independently associated with a higher likelihood of Tdap vaccination included receiving a provider recommendation, Hispanic ethnicity, having two to three physician contacts in the past 12 months, having one or two vaccination providers, and receiving vaccinations from more than one type of facility (p<0.05).

      Conclusions

      Provider recommendations were significantly associated with Tdap vaccination among adolescents aged 13–17 years. However, 43% of parents of adolescents did not receive a provider recommendation. Evidence-based strategies such as standing orders and provider reminders alone or health systems interventions in combination should be taken to improve provider recommendation and Tdap vaccination coverage.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • CDC
        Pertussis epidemic—Washington, 2012.
        MMWR Morb Mortal Wkly Rep. 2012; 61: 517-522
      1. CDC. Pertussis outbreak trends. www.cdc.gov/pertussis/outbreaks/trends.html. Accessed February 29, 2016.

        • CDC.
        Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine—recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Morb Mortal Wkly Rep. 2006; 55: 1-34
        • CDC
        Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 13-15
        • CDC
        National and state vaccination coverage among adolescents aged 13-17 years—United States, 2013.
        MMWR Morb Mortal Wkly Rep. 2014; 63: 625-633
        • Dorell C.G.
        • Yankey D.
        • Byrd K.K.
        • Murphy T.V.
        Hepatitis A vaccination coverage among adolescents in the United States.
        Pediatrics. 2012; 129: 213-221https://doi.org/10.1542/peds.2011-2197
        • Jain N.
        • Hennessey K.
        Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey–Teen, 2006.
        J Adolesc Health. 2009; 44: 561-567https://doi.org/10.1016/j.jadohealth.2008.10.143
        • Lu P.J.
        • Jain N.
        • Cohn A.C.
        Meningococcal conjugate vaccination among adolescents aged 13-17 years, United States, 2007.
        Vaccine. 2010; 28: 2350-2355https://doi.org/10.1016/j.vaccine.2009.12.032
      2. CDC. Preteen and teen vaccines. www.cdc.gov/vaccines/who/teens/for-hcp.html. Accessed February 29, 2016.

      3. CDC. National Immunization Survey–Teen. ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NIS/NISTEENPUF13_DUG.pdf. Accessed February 29, 2016.

      4. Reagan-Steiner S, Elam-Evans LD, JA. Singleton. National Immunization Survey–Teen (NIS-Teen): revised definition of adequate provider data. www.cdc.gov/vaccines/imz-managers/coverage/nis/teen/downloads/APD-full-report.pdf. Accessed July 25, 2016.

      5. CDC. Tdap booster requirements for secondary schools. www.immunize.org/laws/tdap.asp. Accessed March 3, 2016.

        • Dorell C.G.
        • Yankey D.
        • Santibanez T.A.
        • Markowitz L.E.
        Human papillomavirus vaccination series initiation and completion, 2008-2009.
        Pediatrics. 2011; 128: 830-839https://doi.org/10.1542/peds.2011-0950
        • Gust D.A.
        • Darling N.
        • Kennedy A.
        • Schwartz B.
        Parents with doubts about vaccines: which vaccines and reasons why.
        Pediatrics. 2008; 122: 718-725https://doi.org/10.1542/peds.2007-0538
        • Gerend M.A.
        • Weibley E.
        • Bland H.
        Parental response to human papillomavirus vaccine availability: uptake and intentions.
        J Adolesc Health. 2009; 45: 528-531https://doi.org/10.1016/j.jadohealth.2009.02.006
        • Lehmann C.E.
        • Brady R.C.
        • Battley R.O.
        • Huggins J.L.
        Adolescent vaccination strategies: interventions to increase coverage.
        Paediatr Drugs. 2016; 18: 273-285https://doi.org/10.1007/s40272-016-0177-1
        • Dempsey A.F.
        • Zimet G.D.
        Interventions to improve adolescent vaccination: what may work and what still needs to be tested.
        Vaccine. 2015; 33: D106-D113https://doi.org/10.1016/j.vaccine.2015.09.032
      6. Lett S. Evidence-based strategies for increasing HPV vaccination rates. http://mcaap.org/wp2013/wp-content/uploads/2014/04/MCAAP-II-Evidence-Based-Strategies-Improve-HPV-Rates-Webinar-Slides-4-10-14.pdf. Accessed November 17, 2016.

        • Jain N.
        • Stokley S.
        • Cohn A.
        Receipt of tetanus-containing vaccinations among adolescents aged 13 to 17 years in the United States: National Immunization Survey-Teen 2007.
        Clin Ther. 2010; 32: 1468-1478https://doi.org/10.1016/j.clinthera.2010.07.016
        • Enger K.S.
        • Stokley S.
        Meningococcal conjugate vaccine uptake, measured by Michigan’s immunization registry.
        J Adolesc Health. 2007; 40: 398-404https://doi.org/10.1016/j.jadohealth.2006.11.141
        • CDC
        National and state vaccination coverage among adolescents aged 13-17 years—United States, 2008.
        MMWR Morb Mortal Wkly Rep. 2008; 57: 1100-1103
        • CDC
        National and state vaccination coverage among adolescents aged 13-17 years—United States, 2009.
        MMWR Morb Mortal Wkly Rep. 2010; 59: 1018-1023
        • CDC
        National and state vaccination coverage among adolescents aged 13-17 years—United States, 2011.
        MMWR Morb Mortal Wkly Rep. 2012; 61: 671-677
      7. CDC. Vaccination coverage articles and reports. www.cdc.gov/vaccines/imz-managers/coverage/articles.html. Accessed March 3, 2016.

        • Klaiman T.
        • Ibrahim J.K.
        State health department structure and pandemic planning.
        J Public Health Manag Pract. 2010; 16: E1-E7https://doi.org/10.1097/PHH.0b013e3181b83475
        • Nelson D.E.
        • Bland S.
        • Powell-Griner E.
        • et al.
        State trends in health risk factors and receipt of clinical preventive services among U.S. adults during the 1990s.
        JAMA. 2002; 287: 2659-2667https://doi.org/10.1001/jama.287.20.2659
        • CDC
        State and sex specific prevalence of selected characteristics—Behavioral Risk Factor Surveillance System, 1996 and 1997.
        MMWR Morb Mortal Wkly Rep. 2000; 49: 1-39
        • CDC
        Surveillance for certain health behaviors among selected local areas—United States, Behavioral Risk Factor Surveillance System, 2011.
        MMWR Morb Mortal Wkly Rep. 2014; 63: 1-149
        • CDC
        Surveillance of influenza vaccination coverage—United States, 2007-08 through 2011-12 influenza seasons.
        MMWR Morb Mortal Wkly Rep. 2013; 62: 1-29
        • Lee G.M.
        • Santoli J.M.
        • Hannan C.
        • et al.
        Gaps in vaccine financing for underinsured children in the United States.
        JAMA. 2007; 298: 638-643https://doi.org/10.1001/jama.298.6.638
        • Freed G.L.
        • Cowan A.E.
        • Clark S.J.
        Primary care physician perspectives on reimbursement for childhood immunizations.
        Pediatrics. 2008; 122: 1319-1324https://doi.org/10.1542/peds.2008-2033
      8. Rodewald LE Timing of the implementation of new vaccines in the VFC program. Presented at: Centers for Disease Control and Prevention (U.S.)/Agency for Toxic Substances and Disease Registry, Tribal Consultation Advisory Committee meeting; February 10–12, 2009; Albuquerque.

        • Pruitt S.L.
        • Schootman M.
        Geographic disparity, area poverty, and human papillomavirus vaccination.
        Am J Prev Med. 2010; 38: 525-533https://doi.org/10.1016/j.amepre.2010.01.018
        • Freed G.L.
        • Cowan A.E.
        • Gregory S.
        • Clark S.J.
        Variation in provider vaccine purchase prices and payer reimbursement.
        Pediatrics. 2008; 122: 1325-1331https://doi.org/10.1542/peds.2008-2038
        • Lindley M.C.
        • Smith P.J.
        • Rodewald L.E.
        Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009.
        Public Health Rep. 2011; 126: 124-134https://doi.org/10.1177/00333549111260S214
        • CDC
        Use of mass Tdap vaccination to control an outbreak of pertussis in a high school-Cook County, Illinois, September 2006—January 2007.
        MMWR Morb Mortal Wkly Rep. 2008; 57: 796-799
        • Wilson T.R.
        • Fishbein D.B.
        • Ellis P.A.
        • Edlavitch S.A.
        The impact of a school entry law on adolescent immunization rates.
        J Adolesc Health. 2005; 37: 511-516https://doi.org/10.1016/j.jadohealth.2005.07.009
        • Fogarty K.J.
        • Massoudi M.S.
        • Gallo W.
        • Averhoff F.M.
        • Yusuf H.
        • Fishbein D.
        Vaccine coverage levels after implementation of a middle school vaccination requirement, Florida, 1997-2000.
        Public Health Rep. 2004; 119: 163-169https://doi.org/10.1177/003335490411900209
        • Jacobs R.J.
        • Meyerhoff A.S.
        Effect of middle school entry requirements on hepatitis B vaccination coverage.
        J Adolesc Health. 2004; 34: 420-423https://doi.org/10.1016/S1054-139X(03)00343-4
      9. Dolson D. Errors of non-observation: dwelling nonresponse and coverage error in traditional censuses. www.amstat.org/sections/srms/proceedings/y2012/files/303670_71713.pdf. Accessed March 3, 2016.

      10. Ganesh N, Khare M, Ormson EA, et al. Noncoverage adjustments in a single-frame cell-phone survey: weighting approach to adjust for phoneless and landline-only households. www.amstat.org/sections/srms/proceedings/y2014/files/311278_87035.pdf. Accessed July 25, 2016.

      11. Pineau VJ, Wolter KM, Skalland B, Zeng W, Khare M, Zhao Z Assessment of total survey error for the National Immunization Survey (NIS) 2009—2010. www.amstat.org/meetings/jsm/2012/onlineprogram/abstractdetails.cfm?abstractid=304324. Accessed July 25, 2016.

      12. Pineau VJ, Wolter KM, Skalland B, et al. Modeling total survey error in the 2011 National Immunization Survey (NIS): pre-school children and teens. www.cdc.gov/vaccines/imz-managers/coverage/nis/child/downloads/total-survey-error-NIS-2011.pdf. Accessed July 25, 2016.

        • CDC
        The guide to community preventive services.
        The community guide. CDC, Atlanta, GA2013 (Accessed January 13, 2014)
        • CDC
        General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices.
        MMWR Morb Mortal Wkly Rep. 2011; 60